Young adults who follow a plant-based, high-quality diet are less likely to develop diabetes and gain weight through middle age, according to data from the Coronary Artery Risk Development in Young Adults (CARDIA) study.
The degree of the acute decline in estimated glomerular filtration rate (eGFR) following treatment with luseogliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, varies widely among patients with type 2 diabetes, a recent study has found.
In teens with short stature, the combination of gonadotropin releasing hormone analogue (GnRHa) and recombinant human growth hormone (rhGH) yields a significant increase in adult height, as shown in a study.
Use of dipeptidyl-peptidase 4 (DPP-4) inhibitors is linked to the development of bullous pemphigoid, although the risk increase appears to be limited to linagliptin, according to the results of a meta-analysis.
For patients with intermediate-stage hepatocellular carcinoma (HCC) who have undergone transarterial chemoembolization (TACE), long-term survival decreases in the presence of type 2 diabetes (T2D), a study reports.
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.